Kelly John Alexander

Kelly John Alexander is listed in filings as Chief Financial Officer at Precision BioSciences, Inc.. This profile follows SEC Form 4 activity through Feb 19, 2026, including sale activity and purchase activity. Recent filings connect the profile to Precision BioSciences, Inc. (DTIL). The current snapshot covers public activity from Aug 23, 2024 to Feb 19, 2026. Reported amounts are shown as $31.3K to $8.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.